FN1 and astrocytoma (excluding glioblastoma): The results revealed that the original low-grade astrocytoma specimen displayed weak staining of FN protein (Figure 4G) but the recurrent GBM specimen exhibited moderately strong staining of FN protein (Figure 4H), indicating that the FN expression level is increased during malignant transformation of brain cancer.